IHE vs. ARKG ETF Comparison
Comparison of iShares U.S. Pharmaceutical ETF (IHE) to ARK Genomic Revolution Multi-Sector ETF (ARKG)
IHE
iShares U.S. Pharmaceutical ETF
IHE Description
The investment seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index (the "underlying index"), which measures the performance of the pharmaceuticals sector of the U.S. equity market. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$65.67
Average Daily Volume
55,786
34
ARKG
ARK Genomic Revolution Multi-Sector ETF
ARKG Description
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.Grade (RS Rating)
Last Trade
$26.31
Average Daily Volume
2,384,648
37
Performance
| Period | IHE | ARKG |
|---|---|---|
| 30 Days | 3.11% | 1.58% |
| 60 Days | -1.70% | -10.69% |
| 90 Days | -0.93% | -11.05% |
| 12 Months | 11.90% | -11.89% |
0 Overlapping Holdings
| Symbol | Grade | Weight in IHE | Weight in ARKG | Overlap |
|---|
IHE Overweight 34 Positions Relative to ARKG
| Symbol | Grade | Weight | |
|---|---|---|---|
| LLY | C | 23.17% | |
| JNJ | F | 22.03% | |
| MRK | B | 4.93% | |
| PFE | D | 4.85% | |
| RPRX | F | 4.41% | |
| VTRS | C | 4.31% | |
| ZTS | D | 4.29% | |
| CTLT | D | 4.16% | |
| BMY | F | 3.93% | |
| ELAN | B | 3.49% | |
| JAZZ | D | 2.93% | |
| ITCI | C | 2.59% | |
| OGN | B | 2.16% | |
| PRGO | C | 1.73% | |
| PBH | D | 1.44% | |
| AXSM | B | 1.18% | |
| CORT | D | 0.99% | |
| ARVN | D | 0.89% | |
| SUPN | D | 0.67% | |
| AMPH | F | 0.65% | |
| LGND | C | 0.58% | |
| PCRX | D | 0.57% | |
| EWTX | B | 0.53% | |
| COLL | C | 0.51% | |
| HRMY | C | 0.42% | |
| ANIP | D | 0.41% | |
| TARS | B | 0.37% | |
| INVA | B | 0.36% | |
| SAVA | C | 0.35% | |
| PLRX | F | 0.3% | |
| AMRX | B | 0.3% | |
| RVNC | F | 0.16% | |
| TBPH | C | 0.13% | |
| AMLX | F | 0.03% |
IHE Underweight 37 Positions Relative to ARKG
| Symbol | Grade | Weight | |
|---|---|---|---|
| CRSP | F | -7.04% | |
| TWST | B | -6.69% | |
| RXRX | F | -5.94% | |
| EXAS | F | -5.02% | |
| IONS | F | -4.43% | |
| SDGR | F | -4.29% | |
| NTLA | F | -4.12% | |
| CDNA | C | -3.99% | |
| MRNA | B | -3.6% | |
| BEAM | F | -3.59% | |
| ARCT | F | -3.43% | |
| TXG | F | -3.43% | |
| DNA | F | -3.35% | |
| TDOC | F | -3.24% | |
| ACCD | F | -2.99% | |
| VCYT | F | -2.92% | |
| VEEV | D | -2.77% | |
| VRTX | C | -2.61% | |
| NRIX | C | -2.46% | |
| ADPT | D | -2.27% | |
| MASS | F | -1.69% | |
| QSI | D | -1.65% | |
| INCY | D | -1.6% | |
| PACB | F | -1.57% | |
| VERV | F | -1.36% | |
| CMPS | D | -1.31% | |
| PRME | F | -1.25% | |
| REGN | C | -1.22% | |
| ABSI | D | -1.2% | |
| PATH | D | -1.09% | |
| AMGN | B | -1.06% | |
| CERS | C | -1.06% | |
| PSNL | B | -0.77% | |
| BFLY | F | -0.76% | |
| RPTX | F | -0.67% | |
| NTRA | B | -0.57% | |
| GH | D | -0.49% |
IHE: Top Represented Industries & Keywords
ARKG: Top Represented Industries & Keywords
Compare ETFs
